Skip to main content

AI in Life Sciences: Practical applications in small molecule design

AI in Life Sciences: Practical applications in small molecule design

Webcast supported by

Webcast supported by

Wed, 18th June - 3pm BST

In association with

Join us for an insightful online panel discussion exploring how AI is reshaping scientific discovery.

 

The focus will be on small molecule design in the life sciences, agrochemical, and biotech sectors. This session will cut through the noise around AI hype to highlight real-world applications already delivering value across research and development workflows.
 


Key Talking Points
 


AI - Hype or a Useful Tool?
We tackle the critical question: Is AI all buzz or a transformative force? 

By exploring real use cases—including agentic AI that can autonomously answer questions and perform tasks and LLMs that interact with internal data—we’ll show how AI is becoming a practical tool for workflow orchestration and strategic decision-making.
 

AI for Speed and Usability: Low-Code/No-Code Solutions
Discover how AI-driven platforms simplify complex processes, allowing researchers and small businesses to leverage powerful tools without deep technical expertise.

We'll explore how low-code and no-code interfaces accelerate innovation and democratise access to AI, enabling faster, 
more user-friendly scientific workflows.
 


Generative Chemistry: AI for Scientific Discovery
Learn how Generative AI is driving advances in molecule design, enabling the creation of novel compounds with unprecedented speed and efficiency.

This segment will cover pharmaceutical, agrochemical, and academic applications, showcasing AI’s potential to 
revolutionise drug discovery and chemical research.

 


What You'll Learn
 

How to leverage existing foundational models (LLMs) for internal data analysis
 

The role of Agentic AI in automating complex tasks and augmenting R&D productivity

Why academia and small businesses in life sciences are ideal early adopters

 

Opportunities for pharma with on-prem LLMs and biotech access to shared AI infrastructure




How Cresset is ahead of the curve, providing AI-enhanced products, consultancy-based solutions, and customer success support through tailored POCs.

 


 Speakers

 

 

Dr Mutlu Dogruel
VP of AI Solutions, Cresset
Dr. Mutlu Dogruel is the VP of AI Solutions at Cresset, where he leads the integration of AI across the company's drug discovery products and services, focusing on productivity, responsible AI practices, systematic AI deployment, and internal optimisations.
Mutlu has a robust academic background that includes a Bachelor’s degree in physics, a Master's degree in Bioengineering, and a PhD in Bioinformatics from the University of Cambridge. His research focused on applying Machine Learning and statistical methods to computational biology problems, including subcellular localisation prediction and protein motif discovery.

Prior to joining Cresset, Mutlu was the lead Pharma AI Architect at Microsoft UK, where he spent almost eight years designing cloud-based solutions for pharmaceutical and life sciences companies. He also held a genomics consultancy role and worked as an R&D engineer in the speech-to-text domain at Hewlett Packard.
 

 

Whether you work in pharma, agrochemical research, academic science, or biotech innovation, this panel discussion will provide actionable insights into how AI can elevate your work beyond the hype.

Do you want to sponsor this virtual event? Please contact our sales team at sales@europascience.com.

Having trouble registering? For any technical queries, get in touch at webcast@europascience.com.
 

Media Partners